Cargando…
p53 amyloid aggregation in cancer: function, mechanism, and therapy
Similar to neurodegenerative diseases, the concept that tumors are prion like diseases has been proposed in recent years. p53, the most well-known tumor suppressor, has been extensively studied for its expression, mutation, and function in various tumors. Currently, an interesting phenomenon of p53...
Autores principales: | Li, Jingzhi, Guo, Ming, Chen, Lin, Chen, Zhuchu, Fu, Ying, Chen, Yongheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520902/ https://www.ncbi.nlm.nih.gov/pubmed/36171607 http://dx.doi.org/10.1186/s40164-022-00317-7 |
Ejemplares similares
-
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
por: Wei, Hudie, et al.
Publicado: (2023) -
Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis
por: Wei, Hudie, et al.
Publicado: (2021) -
Targeting p53 pathways: mechanisms, structures, and advances in therapy
por: Wang, Haolan, et al.
Publicado: (2023) -
Structure of p53 binding to the BAX response element reveals DNA unwinding and compression to accommodate base-pair insertion
por: Chen, Yongheng, et al.
Publicado: (2013) -
Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils: IMPLICATIONS FOR CANCER
por: Ano Bom, Ana P. D., et al.
Publicado: (2012)